Previously the Live Forever Club — same community, now with a sharper mission for life extension

Business Wire

News provider covering business including public relations, investor relations and distribution & analytics

Business Wire, a Berkshire Hathaway company, is the global leader in press release distribution and regulatory disclosure.

Public relations, investor relations, public policy, and marketing professionals rely on Business Wire for secure and accurate distribution of market-moving news and multimedia.

Founded in 1961, Business Wire is a trusted source for news organizations, journalists, investment professionals, and regulatory authorities, delivering news directly into editorial systems and leading online news sources via its multi-patented NX Network. Business Wire’s global newsrooms are available to meet the needs of communications professionals and news media worldwide.

Visit website: https://www.businesswire.com/portal/site/home/

 BusinessWire

 business-wire

 BusinessWire

Details last updated 04-Feb-2019

Articles sourced from Business Wire

DNA Nanobots raises $3.5m to push non-viral gene delivery T

DNA Nanobots raises $3.5m to push non-viral gene delivery T

Business Wire - 17-Dec-2025

Fresh funding backs DNA origami nanobots aimed at safer, more precise gene therapies

Rubedo doses first patient in landmark trial of anti-aging drug RLS-1496

Rubedo doses first patient in landmark trial of anti-aging drug RLS-1496

Business Wire - 22-May-2025

First GPX4 modulator enters human trials to target senescent cells and combat skin aging

Breaking new ground in anti-ageing science: Bonerge’s 108-person clinical trial

Breaking new ground in anti-ageing science: Bonerge’s 108-person clinical trial

Business Wire - 08-Jan-2025

Synergy of Fisetin, Urolithin A, and Ergothioneine for anti-ageing

Timeline's Mitopure demonstrates potential to reverse immune system ageing

Timeline's Mitopure demonstrates potential to reverse immune system ageing

Business Wire - 06-May-2024

Research underscores potential to revolutionise approach to healthy ageing

DNA Nanobots folds its way to funding for disease-targeting drug delivery

DNA Nanobots folds its way to funding for disease-targeting drug delivery

Business Wire - 24-Jan-2024

Tiny robots made of DNA can now deliver your medicine straight to the cells

A new medicine called JUV-161 might help people with DM1, a rare muscle disease

A new medicine called JUV-161 might help people with DM1, a rare muscle disease

Business Wire - 23-Jan-2024

It improved muscles and slowed down the disease in animals

Estée Lauder is launching a new cream to focus on anti-ageing

Estée Lauder is launching a new cream to focus on anti-ageing

Business Wire - 14-Dec-2023

It's based on sirtuins research and claims to provide visible results in 14 days

Headspace: your one-stop shop for lifelong mental health support

Headspace: your one-stop shop for lifelong mental health support

Business Wire - 31-Oct-2023

Refreshed brand offers end-to-end mental health support, from mindfulness to therapy and psychiatry

Mayo clinic and Oxford nanopore partner up to revolutionise precision medicine

Mayo clinic and Oxford nanopore partner up to revolutionise precision medicine

Business Wire - 19-Oct-2023

Unlocking the secrets of cancer and genetic diseases with nanopore sequencing

Actio Biosciences secures $55M to develop drugs using precision medicine

Actio Biosciences secures $55M to develop drugs using precision medicine

Business Wire - 12-Sep-2023

Lead program targets TRPV4, an ion channel that is involved in several diseases

Rubedo's lead compound targets inflammatory skin disease with selective senolytic approach

Rubedo's lead compound targets inflammatory skin disease with selective senolytic approach

Business Wire - 20-Mar-2023

Rubedo is planning first-in-human studies in multiple skin indications driven by chronic inflammation

Vita Therapeutics raised $31m to develop treatment for genetic diseases and cancers

Vita Therapeutics raised $31m to develop treatment for genetic diseases and cancers

Business Wire - 12-Oct-2022

Cell therapies aiming not only to correct the genetic defect but also repair and heal the muscle cells

Focal Biosciences launched by PSI and Apollo Health Ventures

Focal Biosciences launched by PSI and Apollo Health Ventures

Business Wire - 11-Oct-2022

Aims to treat age-related diseases using advanced cellular reprogramming technologies

Phase 2 clinical trial of lead drug candidate MYMD-1- a therapy for delaying aging

Phase 2 clinical trial of lead drug candidate MYMD-1- a therapy for delaying aging

Business Wire - 26-Jul-2022

Sarcopenia drug trial shows no evidence of toxicity or safety issues

Urolithin A can increase mitochondrial health in living joint tissue and improved mobility

Urolithin A can increase mitochondrial health in living joint tissue and improved mobility

Business Wire - 07-Jul-2022

Mitopure can improve mitochondrial health and counteract age-related muscle function decline

Discarded donor livers to be maintained in Liver ICU in USA by Ochre Bio to discover new therapies

Discarded donor livers to be maintained in Liver ICU in USA by Ochre Bio to discover new therapies

Business Wire - 11-May-2022

Liver ICU main aim-Improve liver transplant processes and discover therapies for liver diseases

Mayo Clinic is excited to collaborate with NaNotics for cancer treatment

Mayo Clinic is excited to collaborate with NaNotics for cancer treatment

Business Wire - 04-Jan-2022

Ultra-low toxicity NaNots could have a wide variety of applications

A tiny brain implant restores sense of touch, even in fingertips

A tiny brain implant restores sense of touch, even in fingertips

Business Wire - 16-Aug-2021

Through stimulating deeper parts of brain, patients can feel and control their limbs

Merger between regeneration companies AgeX and LyGenesis not going ahead

Merger between regeneration companies AgeX and LyGenesis not going ahead

Business Wire - 23-Jul-2021

Both companies to continue with the diverse technologies and product development

Ochre Bio secures $9.6M funding for development of RNA therapies

Ochre Bio secures $9.6M funding for development of RNA therapies

Business Wire - 16-Jun-2021

Convergence of genomic technologies and machine learning digitizes liver biology

Tempus launches a smart handheld device 'Tempus ONE' for oncologists

Tempus launches a smart handheld device 'Tempus ONE' for oncologists

Business Wire - 11-Jan-2021

Relays all information & reports to offer real time solutions to physician problems

Oisín made it to top 10 breakthrough technologies of 2020

Oisín made it to top 10 breakthrough technologies of 2020

Business Wire - 26-Feb-2020

Will begin clinical trials after completing pre-clinical studies

Clinicians identified adults at risk for key health conditions

Clinicians identified adults at risk for key health conditions

Business Wire - 27-Jan-2020

Studies were done by integrating whole-genome sequencing with advanced imaging and blood metabolites

FoxBio is developing small molecule drugs to target ageing diseases

FoxBio is developing small molecule drugs to target ageing diseases

Business Wire - 12-Jul-2018

Antoxerene partners with Juvenescence to discover drugs that clear senescent cells

AgeX Identifies Genes Implicated in Regeneration and Cancer

AgeX Identifies Genes Implicated in Regeneration and Cancer

Business Wire - 02-Jan-2018

Study that reveals genes implicated in tissue regeneration, cancer, and aging. Worked in collabo...

Esthetic and efficient revolutionary cornea implant

Esthetic and efficient revolutionary cornea implant

Business Wire - 06-Oct-2017

A nanotechnology-based solution to bring new hope to millions of blind and visually-impaired

Atlas Biomed Launches Personalised Health Testing for UK Consumers

Atlas Biomed Launches Personalised Health Testing for UK Consumers

Business Wire - 31-Jul-2017

DNA and gut microbiome tests with integrated analysis on the company’s health platform. Select p...

Proclara Biosciences raised $47 million funding to advance treatment for neurodegenerative diseases

Proclara Biosciences raised $47 million funding to advance treatment for neurodegenerative diseases

Business Wire - 07-Sep-2016

Relaunches as a clinical-stage company, with phase 1 clinical trials of lead compound for Alzheimer’s

Cambridge Medical Robotics unveils next-generation robotic surgery

Cambridge Medical Robotics unveils next-generation robotic surgery

Business Wire - 20-Nov-2015

Modular surgical system that uses multiple collaborative robotic arms for universal minimal acces...

DoNotAge supplements affiliate link